Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.
Wils JA, Klein HO, Wagener DJ, Bleiberg H, Reis H, Korsten F, Conroy T, Fickers M, Leyvraz S, Buyse M, et al. Wils JA, et al. Among authors: fickers m. J Clin Oncol. 1991 May;9(5):827-31. doi: 10.1200/JCO.1991.9.5.827. J Clin Oncol. 1991. PMID: 2016625 Clinical Trial.
Adjuvant chemohormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive breast cancer patients.
Hupperets PS, Wils J, Volovics L, Schouten L, Fickers M, Bron H, Schouten HC, Jager J, Smeets J, de Jong J, et al. Hupperets PS, et al. Among authors: fickers m. Ann Oncol. 1993 Apr;4(4):295-301. doi: 10.1093/oxfordjournals.annonc.a058485. Ann Oncol. 1993. PMID: 8518219 Free article. Clinical Trial.
Adjuvant chemo-hormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive cancer patients. Update at 7-year follow-up.
Hupperets P, Wils J, Volovics L, Schouten L, Fickers M, Bron H, Schouten H, Jager J, de Jong J, Beex L, et al. Hupperets P, et al. Among authors: fickers m. Ann Oncol. 1995 Jan;6(1):90-1. doi: 10.1093/oxfordjournals.annonc.a059059. Ann Oncol. 1995. PMID: 7710989 Free article. Clinical Trial. No abstract available.
Adjuvant chemo-hormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate (MPA) for node-positive cancer patients, update at 12 years follow up.
Hupperets PS, Wils JA, Volovics L, Schouten LJ, Fickers MM, Bron HN, Jager JJ, de Jong JM, Blijham GH. Hupperets PS, et al. Among authors: fickers mm. Breast. 2001 Feb;10(1):35-7. doi: 10.1054/brst.2000.0180. Breast. 2001. PMID: 14965556 Clinical Trial.
High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.
Poortmans PM, Kluin-Nelemans HC, Haaxma-Reiche H, Van't Veer M, Hansen M, Soubeyran P, Taphoorn M, Thomas J, Van den Bent M, Fickers M, Van Imhoff G, Rozewicz C, Teodorovic I, van Glabbeke M; European Organization for Research and Treatment of Cancer Lymphoma Group. Poortmans PM, et al. Among authors: fickers m. J Clin Oncol. 2003 Dec 15;21(24):4483-8. doi: 10.1200/JCO.2003.03.108. Epub 2003 Nov 3. J Clin Oncol. 2003. PMID: 14597741 Clinical Trial.
Interferon-alpha as maintenance therapy in patients with multiple myeloma.
Schaar CG, Kluin-Nelemans HC, Te Marvelde C, le Cessie S, Breed WP, Fibbe WE, van Deijk WA, Fickers MM, Roozendaal KJ, Wijermans PW; Dutch-Belgian Hemato-Oncology Cooperative Group HOVON. Schaar CG, et al. Among authors: fickers mm. Ann Oncol. 2005 Apr;16(4):634-9. doi: 10.1093/annonc/mdi125. Epub 2005 Mar 1. Ann Oncol. 2005. PMID: 15741226 Free article. Clinical Trial.
26 results